TPG-backed Par Pharmaceuticals to acquire JHP Pharmaceuticals

TPG-backed Par Pharmaceutical Companies has agreed to acquire the parent company of JHP Pharmaceuticals, a specialty pharmaceuticals business that develops, manufactures and markets branded and generic sterile injectable products. Par expects to close the deal in the first quarter.

DealsNorth AmericaUSBriefs